[Liver cirrhosis and therapy issues].
Child-Pugh criteria are reliable markers of efficiency of the protective therapy of the liver in patients with liver cirrhosis. The protective therapy of the liver with ursodeoxycholic acid has positive effect on main clinical signs of liver cirrhosis and enables for certainty the decrease in dystrophic and increase in reparative processes in hepatocyte, increase in survival rate of patients during two years.
Shypulin
V P
VP
D000368:Aged; D001663:Bilirubin / Q000097:blood; D002756:Cholagogues and Choleretics / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D022781:Hepatocytes / Q000187:drug effects / Q000473:pathology; D006801:Humans; D008103:Liver Cirrhosis / Q000097:blood / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D008297:Male; D010743:Phospholipids / Q000008:administration & dosage / Q000627:therapeutic use; D011517:Prothrombin Time; D012709:Serum Albumin / Q000032:analysis; D012720:Severity of Illness Index; D008063:Thioctic Acid / Q000008:administration & dosage / Q000627:therapeutic use; D016896:Treatment Outcome; D014580:Ursodeoxycholic Acid / Q000008:administration & dosage / Q000627:therapeutic use*
D002756:Cholagogues and Choleretics; D010743:Phospholipids; D012709:Serum Albumin; D014580:Ursodeoxycholic Acid; D008063:Thioctic Acid; D001663:Bilirubin